MolecularMD, Asterand Bioscience Form Biomarker Alliance | GenomeWeb

NEW YORK (GenomeWeb) – MolecularMD has partnered with Asterand Bioscience to provide its biopharma customers with an end-to-end workflow for biomarker and cancer drug target validation, and assay development, the companies announced today.

Under the terms of the deal, MolecularMD will access Asterand's human tissue procurement, characterization, and research services to assist with the development of custom clinical trial assays and companion diagnostic products for its clients. Specific details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.